TheraRadar
← Back
Data updated: Mar 29, 2026

BEIJING TIDE PHARM

RespiratoryOncologyGastroenterology
Generics

BEIJING TIDE PHARM is a generic drug manufacturer focused on Respiratory, Oncology, Gastroenterology.

2021
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-18
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 57%
0 drugs Phase 3: 1
Oncology 29%
0 drugs Phase 1: 2
Gastroenterology 14%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Gastroenterology, Respiratory
Novartis big-pharma
Oncology, Respiratory
GSK big-pharma
Respiratory, Oncology
Sanofi big-pharma
Oncology, Respiratory